Arit Industries in the First Quarter: Backlog Is Advancing, but Reshef Dilution Is Already Visible

The first quarter of 2026 strengthens the view that Arit Industries did not immediately lose the step-up it achieved in 2025, but it also makes the story less clean. Reshef's operating business is still strong: revenue rose, gross margin improved, and the company enters the next quarters with backlog that covers a meaningful part of the year plus a longer layer tied to India. Still, two things have to hold at the same time for the read to stay constructive: backlog must turn into timely deliveries, and Reshef's economics must reach Arit shareholders after dilution, dividends, and the new cash structure. Consolidated net profit rose 33%, but profit attributable to the company's shareholders rose only 12%, already showing the cost of moving to a 77.6% holding in Reshef. The shareholder dividend also rests on the cash built in 2025 and on a dividend upstreamed from Reshef, not on quarterly operating cash flow that independently covers the whole distribution. This is a good quarter, but not one that closes the question opened after the 2025 analysis: whether Arit has moved to a new earnings base, or is still benefiting from a peak year, a large cash balance, and backlog that still has to become orders, production, and cash.

Backlog Is Large, but Not Uniform

Arit Industries is effectively a holding company around one core operating asset: Reshef Technologies, which develops, manufactures, and markets electronic fuzes for defense customers in Israel and globally. The business sits in defense, but its economics look like a project-based industrial company: large orders, few customers, delivery schedules, advances, inventory, and revenue recognition tied to production and shipment timing.

That makes backlog the quarter's key number. As of March 31, 2026, it stood at NIS 571.9 million excluding a conditional order, and NIS 732.5 million including a conditional order of about $50.7 million under the BEL agreement. Near the approval date of the financial statements, backlog including the conditional order was about NIS 710 million, still a high level relative to quarterly activity.

But backlog quality matters almost as much as its size. Backlog for 2026, including first-quarter revenue already recognized, is about NIS 366 million. Of that, the first quarter contributed NIS 76.7 million, and the table shows another NIS 78.6 million for the second quarter, NIS 107.1 million for the third quarter, and NIS 103.5 million for the fourth quarter. The implication is straightforward: even after a strong quarter, moving close to the 2025 peak year requires additional orders for 2026 delivery or faster delivery beyond what is already in the table.

The less comfortable point sits inside the definitions. On the one hand, the company says orders included in backlog are binding, and that negotiations or expected orders are not included. On the other hand, the backlog excluding the conditional order includes about $89 million from the BEL agreement for the operational order for years 3 to 10, which is expected to be received later under the agreement's terms. That does not cancel the backlog, but it does mean the backlog is not uniform: part of it is closer to 2026 deliveries, while part is a multi-year agreement layer that still depends on the execution path in India.

Concentration also remains high. In the backlog excluding the conditional order, two main customers represent 36% and 63% of orders. Including the conditional order, they represent 28% and 71%. The company does not name the customers in the backlog table, but the risk structure is clear enough. Geographic expansion has not yet become broad diversification. Growth still depends on a small number of large relationships, which can be a source of customer depth in defense or a warning sign of dependence.

Profitability Holds, Shareholder Profit Grows More Slowly

Operating performance in the quarter looks strong. Revenue rose to NIS 76.7 million from NIS 66.9 million in the parallel quarter, an increase of about 14.6%. Gross profit rose to NIS 51.1 million, and gross margin reached about 66.6%, compared with about 62.7% in the parallel quarter. The operating explanation is positive: more revenue against fixed costs, a more profitable product mix, and efficiency gains.

Still, the line that matters most for Arit shareholders is not consolidated profit alone. Consolidated net profit rose from NIS 32.1 million to NIS 42.7 million, growth of about 33%, but profit attributable to the company's shareholders rose from NIS 32.0 million to only NIS 35.9 million, growth of about 12%. The gap comes from Reshef's profit now also flowing to non-controlling interests, which reached NIS 6.8 million in the quarter, compared with almost nothing in the parallel quarter.

This does not mean the dilution was negative. Reshef received capital, Arit received cash, and the group exited 2025 with a much stronger balance sheet. But the first quarter makes the right reading of 2026 clearer: the question is not only how much Reshef earns, but how much of that profit remains with Arit shareholders after the capital move. If Reshef keeps expanding the earnings base, 77.6% can still be worth more than near-full ownership of a smaller business. If growth stalls, the dilution cost will become more visible.

Cash Is There, but the Dividend Uses the Existing Balance Sheet

The group's liquidity position remains unusually strong. At quarter-end, the group held NIS 671.9 million in cash and cash equivalents and another NIS 672.2 million in financial assets measured at fair value. Bank debt is almost nonexistent, and funding is based mainly on internal resources and customer advances. This is not the balance sheet of a company fighting for financing.

But balance-sheet flexibility is not the same as quarterly cash flow funding shareholder distributions. Operating cash flow in the quarter was only NIS 17.0 million. Net profit was NIS 42.7 million, and the decline in receivables generated meaningful cash inflow, but NIS 82.8 million of tax payments absorbed much of the benefit. At the same time, the group purchased about NIS 335 million net of financial assets, while financing cash inflow was NIS 292.6 million from the issuance, sale of bundled securities, and warrant exercises.

All-in cash flexibility after the quarter's actual cash uses shows money moving between layers rather than a funding shortage: consolidated cash fell by about NIS 25.8 million, but financial assets rose by about NIS 331.4 million. At the parent-company level, the picture is sharper. Cash fell from NIS 204.2 million at year-end 2025 to NIS 53.4 million at March 31, 2026, while parent-level financial assets rose to NIS 569.8 million and a NIS 161.6 million dividend receivable from a subsidiary was booked.

Therefore, the NIS 78.3 million dividend declared in March, and the additional NIS 26 million distribution approved after the reporting date, are mainly a use of the cash built in 2025 and the Reshef warrant-exercise cycle. That is positive for value access to Arit shareholders, because some value is indeed moving up from Reshef. But it is not proof that the current quarter alone funds that distribution pace. The next reports need to show whether Reshef can continue upstreaming cash without hurting the investments required for India, Europe, and the United States.

What Will Decide the Next Read

The first quarter turns 2026 into a proof year rather than a bridge year. Arit no longer has to prove that demand exists for Reshef's fuzes or that it has a strong balance sheet. It has to prove that backlog converts into deliveries at a sufficient pace, that the Indian layer receives follow-on orders and letters of credit, that Europe turns the agreement into orders, and that the United States and loitering-munition activity do not remain only potential.

Post-quarter events help, but they differ in certainty. In Israel, Reshef received a NIS 42 million Ministry of Defense order and another NIS 28 million award for a new fuze type with a 90% quantity option, but that tender also had another winner and the company is aware of an Israeli competitor in that specific fuze type. In India, Reshef's expected share from one tender is about $4.4 million and its expected share from an export order is about $2.2 million, but the export order still depends on BEL issuing a component order and on export approval. In Europe, the commercial agreement leaves Reshef with about 70% of the sale price on average according to the company's estimate, but it still needs to become actual orders. The Israel Securities Authority search in February 2026 does not change operations, but it adds governance noise around a company the market measures by execution confidence.

The current read leans positive because profitability is high, backlog is large, and the balance sheet gives the company time to execute. The main hurdle is conversion quality: long-dated and conditional orders must become revenue, Reshef profits must reach Arit shareholders, and shareholder distributions should eventually rest on recurring cash flow rather than only on the balance sheet built in an unusual year. If revenue in the next quarters tracks the 2026 backlog, gross margin remains near current levels, and India or Europe add firm orders, the market will get more evidence that 2025 was not a one-off peak. If deliveries slip, backlog remains concentrated and conditional, or Arit shareholders' share of profit erodes too quickly relative to consolidated profit, the reports will look weaker than the operating headline suggests.